Brief: Ceryvyn Therapeutics Posts FY Profit Attributable A$330.4 Million
31/08/2026 11:22
BRIEF-Ceryvyn Therapeutics Posts FY Profit Attributable A$330.4 Million Aug 31 (Reuters) - Ceryvyn Therapeutics Ltd CYV.AX:
FY PROFIT ATTRIBUTABLE A$330.4 MILLION
Further company coverage: CYV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceryvyn Therapeutics
See all newsBrief: Ceryvyn Therapeutics Posts FY Profit Attributable A$330.4 Million
Brief: Opthea To Recommence Trading On ASX On Or Around June 3, 2026
Brief: Opthea Says Hamish George Assumes Role Of CFO
Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln
Australia's Opthea cuts 80% staff, key executives to exit in deal to avert bankruptcy (updated)